Neurotech International Limited Stock
Equities
NTI
AU000000NTI9
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 AUD | 0.00% | -6.25% | +30.43% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Sales 2022 | 608K 397K | Sales 2023 | 1.19M 780K | Capitalization | 34.96M 22.83M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.96M | Net income 2023 | -7M -4.57M | EV / Sales 2022 | 77.3 x |
Net cash position 2022 | 1.9M 1.24M | Net cash position 2023 | 5.03M 3.28M | EV / Sales 2023 | 25.1 x |
P/E ratio 2022 |
-14.5
x | P/E ratio 2023 |
-4.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.08% |
1 week | -6.25% | ||
Current month | -18.18% | ||
1 month | -14.29% | ||
3 months | +5.88% | ||
6 months | +47.54% | ||
Current year | +30.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 22-03-07 | |
Erlyn Dawson
SEC | Corporate Secretary | - | 19-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Davies
CHM | Chairman | - | 19-04-15 |
Thomas Duthy
BRD | Director/Board Member | - | 22-08-31 |
Gerald Quigley
BRD | Director/Board Member | - | 22-07-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.09 | 0.00% | 1,439,697 |
24-04-24 | 0.09 | -2.17% | 6,485,682 |
24-04-23 | 0.092 | 0.00% | 1,334,951 |
24-04-22 | 0.092 | -4.17% | 1,042,802 |
24-04-19 | 0.096 | +1.05% | 2,541,781 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+30.43% | 59.71M | |
+4.55% | 3.48B | |
-12.80% | 156M | |
-15.69% | 81.85M |
- Stock Market
- Equities
- NTI Stock